| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/10/2009 | CA2329776C Antibody against lar phosphatase subunit |
| 02/10/2009 | CA2284136C Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
| 02/10/2009 | CA2165197C Recombinant stratum corneum chymotryptic enzyme (scce) |
| 02/05/2009 | WO2009018587A2 Derivation of neural stem cells from embryonic stem cells and methods of use thereof |
| 02/05/2009 | WO2009018453A1 Differentiation of human embryonic stem cells |
| 02/05/2009 | WO2009018103A1 Methods of reducing intracellular fats from mammalian cells |
| 02/05/2009 | WO2009017655A2 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof |
| 02/05/2009 | WO2009017460A1 Method for identifying and selecting cardiomyocytes |
| 02/05/2009 | WO2009017321A2 Co-culture method of skin cells and cell therapy composition using the same |
| 02/05/2009 | WO2009017269A1 A method for differentiating of human embryonic stem cells into the osteoblastic lineage |
| 02/05/2009 | WO2009017267A1 Method for differenciating mesenchymal stem cell and culturing chondrocytes using alginate coated fibrin/ha composite scaffold |
| 02/05/2009 | WO2009017255A1 Method for specific regulation of toll-like receptor/interleukin-18 signaling by mutation-introduced myd88 protein |
| 02/05/2009 | WO2009017254A1 Method for constructing mass of myocardial cells and use of the myocardial cell mass |
| 02/05/2009 | WO2009016842A1 Microfluidicdevice for trapping single cell |
| 02/05/2009 | WO2009016839A1 Method for measurement of concentration of antigen |
| 02/05/2009 | WO2009016518A2 Biological mesh tissue engineering support |
| 02/05/2009 | WO2009016326A2 Adeno-associated viral vectors for the expression of dysferlin |
| 02/05/2009 | WO2009016262A1 Stem cells derived from the carotid body and uses thereof |
| 02/05/2009 | WO2009016078A2 Method for culturing mammalian stem cells |
| 02/05/2009 | WO2009015840A2 Polypeptide for targeting of neural cells |
| 02/05/2009 | WO2009015628A1 Immortalized keratinocyte cell line and method for measuring protective agents |
| 02/05/2009 | WO2008151386A8 Megakaryocyte differentiation |
| 02/05/2009 | WO2008148028A3 Methods and apparatuses for separating biological particles |
| 02/05/2009 | WO2008145133A3 Method for manufacturing a recombinant polyclonal protein |
| 02/05/2009 | WO2008144052A3 Bioluminescent imaging of stem cells |
| 02/05/2009 | WO2008142129A3 Partially degradable scaffolds for biomedical applications |
| 02/05/2009 | WO2008054606A3 High affinity human antibodies to human il-4 receptor |
| 02/05/2009 | WO2006100673A3 Methods of individually optimizing treatment for an inflammation associated disease |
| 02/05/2009 | WO2006030442A3 Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells |
| 02/05/2009 | WO2005089420A3 Expansion of neural stem cells with lif |
| 02/05/2009 | US20090038034 Polynucleotides Encoding Stop Codons in Multiple Reading Frames and Methods of Use |
| 02/05/2009 | US20090038033 Wood and cell wall gene microarray |
| 02/05/2009 | US20090038027 Msca1 nucleotide sequences impacting plant male fertility and method of using same |
| 02/05/2009 | US20090038026 Msca1 nucleotide sequences impacting plant male fertility and method of using same |
| 02/05/2009 | US20090038023 Lyase Enzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them |
| 02/05/2009 | US20090038022 IGF-1 Novel peptides |
| 02/05/2009 | US20090036648 EGVI Endoglucanase and Nucleic Acids Encoding the Same |
| 02/05/2009 | US20090036540 Guanylhydrazones in Methods of Treatment or Diagnosis as Modulators of Signal Transduction |
| 02/05/2009 | US20090036527 Therapeutic Application Of Leonurine In Treating Cardiomyopathy |
| 02/05/2009 | US20090036524 Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kappab |
| 02/05/2009 | US20090036431 Cytotoxic Agents Comprising New Tomaymycin Derivatives |
| 02/05/2009 | US20090036398 Human G-Protein Coupled Receptor (HETGQ23) |
| 02/05/2009 | US20090036395 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 02/05/2009 | US20090036391 Modulation of line-1 reverse transcriptase |
| 02/05/2009 | US20090036387 Novel chemical entities affecting neuroblastoma tumor-initiating cells |
| 02/05/2009 | US20090036381 Treatment of diabetes |
| 02/05/2009 | US20090036378 Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis |
| 02/05/2009 | US20090036374 Hepatocyte growth factor receptor splice variants and methods of using same |
| 02/05/2009 | US20090036370 Leukocyte Adhesion Inhibitor-1 (LAI-1) |
| 02/05/2009 | US20090036358 Methods of preparing pharmaceutical compositions for treatment of factor Vlll associated disorders and methods of use |
| 02/05/2009 | US20090036318 Class II Human Histone Deacteylases, and Uses Related Thereto |
| 02/05/2009 | US20090035875 Cytochrome C And Leucine-Rich Alpha-2-Glycoprotein-1 Assays, Methods, And Antibodies |
| 02/05/2009 | US20090035860 Stem cell growth media and methods of making and using same |
| 02/05/2009 | US20090035859 Method and devices for preventing restenosis in cardiovascular stents |
| 02/05/2009 | US20090035858 Tissue engineering support |
| 02/05/2009 | US20090035857 Cell culture processing devices and methods |
| 02/05/2009 | US20090035856 Continuous perfusion bioreactor system |
| 02/05/2009 | US20090035855 Three-dimensional reconstituted extracellular matrices as scaffolds for tissue engineering |
| 02/05/2009 | US20090035853 Tsg101-gag interaction and use thereof |
| 02/05/2009 | US20090035852 Stable Atomic Quantum Clusters, Production Method Thereof and Use of Same |
| 02/05/2009 | US20090035851 Modulators Of NOD1 Signaling |
| 02/05/2009 | US20090035850 P49/STRAP is a novel protein involved in gene regulation and cell proliferation |
| 02/05/2009 | US20090035836 Modulating ph-sensitive binding using non-natural amino acids |
| 02/05/2009 | US20090035819 CA125 gene and its use for diagnostic and therapeutic interventions |
| 02/05/2009 | US20090035805 C3A Serum-Free Clonal Cell Line and Methods of Use |
| 02/05/2009 | US20090035804 CONSTITUTIVELY OPEN hERG (Kv11.1) MUTANT CHANNELS |
| 02/05/2009 | US20090035799 Novel trypsin family serine proteases |
| 02/05/2009 | US20090035791 Neural Colony Forming Assay |
| 02/05/2009 | US20090035788 Genetically encoded bioindicators of calcium-ions |
| 02/05/2009 | US20090035783 Fluorescent proteins and uses thereof |
| 02/05/2009 | US20090035771 gene expression; probes, primers, antibodies |
| 02/05/2009 | US20090035747 Nucleic Acid and Gene Derived from Novel HCV Strain and Replicon-Replicating Cell Using Said Gene |
| 02/05/2009 | US20090035552 Composite materials comprising supported porous gels |
| 02/05/2009 | US20090035376 Stem cells obtained from pulp of deciduous or permanent teeth and of dental germ, able to produce human bone tissue |
| 02/05/2009 | US20090035349 Composite scaffolds and methods using same for generating complex tissue grafts |
| 02/05/2009 | US20090035347 Isolated stromal cells and methods of using the same |
| 02/05/2009 | US20090035346 Methods and Compositions for Enhancing Vascular Access |
| 02/05/2009 | US20090035327 Antibody Gene Transfer and Recombinant AAV Therefor |
| 02/05/2009 | US20090035316 Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC) |
| 02/05/2009 | US20090035312 Tumor angiogenesis associated genes and a method for their identification |
| 02/05/2009 | US20090035310 Cancer treatment |
| 02/05/2009 | US20090035307 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES |
| 02/05/2009 | US20090035299 Methods and compositions for treating diseases targeting MABA1 |
| 02/05/2009 | US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/05/2009 | US20090035291 Therapeutic use of adpase enhanced apyrases |
| 02/05/2009 | US20090035289 Dry platelet composition |
| 02/05/2009 | US20090035287 Atrial natriuretic peptide (anp) splice variants and methods of using same |
| 02/05/2009 | US20090035285 Compositions and Methods for Enrichment of Neural Stem Cells Using Ceramide Analogs |
| 02/05/2009 | US20090035284 Derivation of neural stem cells from embryonic stem cells and methods of use thereof |
| 02/05/2009 | US20090035282 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 02/05/2009 | US20090035266 Immunogenic peptides and methods of use |
| 02/05/2009 | US20090035265 Compositions and Methods for Targeted Delivery of Factors |
| 02/05/2009 | US20090035261 for treating degenerative cartilaginous disorders and other inflammatory diseases; inhibiting the proliferation of T-lymphocytes; modulating infiltration of inflammatory cells into a tissue of a mammal |
| 02/05/2009 | US20090035257 Devices, compositions and methods for the protection and repair of cells and tissues |
| 02/05/2009 | US20090035255 Conjugate for targeting of drug |
| 02/05/2009 | US20090035254 IL-21 Variants |
| 02/05/2009 | US20090032463 Composite materials comprising supported porous gels |
| 02/05/2009 | US20090032411 Method and system for detecting pharmacologically active substances by measuring membrane currents with extracellular sensors |
| 02/05/2009 | CA2817054A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | CA2697127A1 Adeno-associated viral vectors for the expression of dysferlin |